Skip to main content

Collaborate with Us

Collaborative research is vital to the Duke Division of Abdominal Transplant Surgery research program.

Our physicians collaborate with leading academic researchers and scientists from various disciplines to advance state-of-the-art medicine through innovation and rigorous science.

Current Collaborations

  • Biomarker Factory: The Innate Immunity in Transplantation Lab is collaborating with the Biomarker Factory for a study entitled "Novel biomarkers for early detection of kidney transplant rejection." 
  • Pfizer: In April 2015, the Innate Immunity in Transplantation Lab will begin a study in collaboration with Pfizer called "Immune function of human leukocytes following Tofacitinib administration."
  • Merck: The Innate Immunity in Transplantation Lab will soon begin a collaboration with Merck studying the "Role of RORgT inhibition in the prevention of allograft rejection."
  • Epinomics: Also in the near future, a collaboration between the Innate Immunity in Transplantation Lab and Epinomics will begin a study called, "Immune monitoring of kidney transplant recipients using Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq)."

Collaborate with Us

To engage with our division in research efforts, please contact us.